Figure 2: Targeting SPP1+ tumor-associated macrophages enhances the anti-tumor immune response in radiotherapy combination therapy. (IMAGE)

Research

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Expert Contacts

Wenjun Mao
Department of Thoracic Surgery, The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi People’s Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China.
maowenjun1@njmu.edu.cn

Bufu Tang
Department of Interventional Radiology, Zhongshan Hospital, Shanghai Institute of Medical Imaging, Shanghai Institution of Medical Imaging, Shanghai, National Clinical Research Center of Interventional Medicine, Fudan University, Shanghai 200032, China.
tangbufu@zju.edu.cn

Songhua Cai
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China.
caisonghua@cicams-sz.org.cn

Figure 2: Targeting SPP1+ tumor-associated macrophages enhances the anti-tumor immune response in radiotherapy combination therapy. (IMAGE)

Caption

Credit

Usage Restrictions

License